About
Treatments for Rare or Neglected Diseases
Areas of Focus
Categories
Generic DrugWound Healing
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
5,110
By Phase
PHASE2: 4PHASE1: 1NA: 1PHASE4: 1
By Status
COMPLETED: 6UNKNOWN: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06578507Lead Sponsor
Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease
PHASE2Recruiting
50 participants
Started: Jan 21, 2025 · Completed: Feb 28, 2027
NCT05470270Lead Sponsor
Acceptability of a New Paediatric Formulation of Hydroxycarbamide in Children With Sickle Cell Disease.
PHASE2Completed
33 participants
Started: Jul 8, 2022 · Completed: Oct 28, 2022
NCT05025072Lead Sponsor
A Bioequivalence Study to Compare the Pharmacokinetics of Two Formulations of Siklos® in Healthy Volunteers
PHASE1Completed
28 participants
Started: Aug 22, 2021 · Completed: Sep 29, 2021
NCT04707235Lead Sponsor
ESCORT-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study
N/AActive, not recruiting
2,093 participants
Started: Aug 21, 2020 · Completed: Aug 21, 2025
NCT03806452Lead Sponsor
SIKAMIC (SIklos on Kidney Function and AlbuMInuria Clinical Trial)
PHASE2Completed
86 participants
Started: May 28, 2019 · Completed: May 30, 2024
Locations (1)
Headquarters
Paris, France
Map
Loading map...